InsidersTradesSigma
Dr. Lal Path Labs Ltd.: directors' dealings · India · SEBI (PIT + SAST)
SEBI:dr-lal-path-labs-ltdIN·SEBI (PIT + SAST)Mcap 206.6Bn€
Explore the full management transaction log of Dr. Lal Path Labs Ltd., a listed equity based in India. Shares are quoted on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €206.6bn. The latest transaction was filed on 24 February 2026 — Purchase. Among the most active insiders: Dr. Lal PathLabs Employees Welfare Trust. All data is openly available.
875
Insider Decl.
0
Thresholds
€11m
354 ops.
Buy Volume
€87m
520 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
1646.30 €
Income statement
Revenue24.61 Bn€
Gross profit16.38 Bn€67% margin
Net income4.87 Bn€19.8% margin
Balance sheet & cash
Market cap206.62 Bn€
Total debt1.57 Bn€
Free Cash Flow5.15 Bn€
Last declaration on 24 February 2026
Declarations875 total
Executives●Purchase0SEBI
€14,3301,500 shares@ €9.5534
Equity Shares
SEBI:fbbdfb416836614c2045b4fde14279f6c6b90cf2·
Ideal exit: 21 Nov 2026 (T+270)
Executives●Sale0SEBI
€14,3542,024 shares@ €7.0921
Equity Shares
SEBI:09943fcf986cfecd303497d8702237d004d71541·
Executives●Sale0SEBI
€6,1961,876 shares@ €3.3028
Equity Shares
SEBI:3ca758f4a95e8e80365714821d8905de69f0b4d2·
Executives●Pledge0SEBI
€33,3842,470 shares@ €13.5156
Equity Shares
SEBI:0d764ee1ff035e91e70600a162c85f1244f3235c·
Executives●Purchase0SEBI
€5,6654,000 shares@ €1.4163
Equity Shares
SEBI:bb6e9970ba4bc5c9e61412678dbbdffc6f09e630·
Ideal exit: 27 Oct 2026 (T+270)
Executives●Sale0SEBI
€34,5292,500 shares@ €13.8118
Equity Shares
SEBI:4f736f5a04ffdc28c700aab6002e93065456fef2·
Executives●Sale0SEBI
€24,0091,750 shares@ €13.7192
Equity Shares
SEBI:af7d6c0111386e0ac314f4271d2e5ad10b4c6d89·
Executives●Purchase0SEBI
€24250 shares@ €0.0978
Equity Shares
SEBI:41923ec0102249f604a2a371b38e826f98f67dc8·
Ideal exit: 1 Aug 2026 (T+270)
Executives●Sale0SEBI
€24,0264,424 shares@ €5.4309
Equity Shares
SEBI:fe8d3542291268e73082c4d5edbdb0e6518b0f2a·
Executives●Purchase0SEBI
€20424 shares@ €0.0472
Equity Shares
SEBI:e40c05b41d2a005c1c9a69a431a75a750b6dd907·
Ideal exit: 26 Sept 2026 (T+270)
Executives●Purchase0SEBI
€23,9362,500 shares@ €9.5742
Equity Shares
SEBI:bc09e0ecd4ebc8d1f6043ffb116af6837e5e30ae·
Ideal exit: 26 Sept 2026 (T+270)
Executives●Purchase0SEBI
€2362,500 shares@ €0.0944
Equity Shares
SEBI:ae6813ba5062052a6ad289ad8eca4118ad7ce7ff·
Ideal exit: 11 Sept 2026 (T+270)
Executives●Sale0SEBI
€9,4704,350 shares@ €2.1771
Equity Shares
SEBI:03c18163a15f9074fd5a6990aafca60bc12b3109·
Executives●Purchase0SEBI
€42450 shares@ €0.0944
Equity Shares
SEBI:3923c6bdcf7d84168a978e8a5a587ef9c7aa20a0·
Ideal exit: 11 Sept 2026 (T+270)
Executives●Purchase0SEBI
€71750 shares@ €0.0944
Equity Shares
SEBI:8034458aba519b94b4b037c9c9f22d0cb030aaa2·
Ideal exit: 11 Sept 2026 (T+270)
Executives●Sale0SEBI
€4,737686 shares@ €6.9056
Equity Shares
SEBI:cdea453e786a35f74e4d713d78b28e4d4b8371dc·
Executives●Sale0SEBI
€3123,200 shares@ €0.0975
Equity Shares
SEBI:ee0faa3b258fd5d5b5093b748dda3e7973f98209·
Executives●Purchase0SEBI
€3123,200 shares@ €0.0975
Equity Shares
SEBI:9998a8c02e4f59f5b27389fa56a33dd7269d79b0·
Ideal exit: 9 Aug 2026 (T+270)
Executives●Sale0SEBI
€6,1191,436 shares@ €4.2614
Equity Shares
SEBI:6a74ab8828f386470d11afc4d084361109327905·
Executives●Purchase0SEBI
€93950 shares@ €0.0976
Equity Shares
SEBI:dfd2fea136d8f5c3649a453c14dcffeb9ef53776·
Ideal exit: 4 Aug 2026 (T+270)
Executives●Purchase0SEBI
€5135,250 shares@ €0.0978
Equity Shares
SEBI:36399c027fb0be145dbad3f2f718af66be196d49·
Ideal exit: 1 Aug 2026 (T+270)
Executives●Sale0SEBI
€5625,750 shares@ €0.0978
Equity Shares
SEBI:853c5934e66c33a88f76b8c0b567fe752088081b·
Executives●Sale0SEBI
€89,8813,000 shares@ €29.9605
Equity Shares
SEBI:21be029353ef2e4a3ef39fd7f5a390098a678cba·
Executives●Sale0SEBI
€3,156450 shares@ €7.0128
Equity Shares
SEBI:5c5560ae75b3d066e61cf1123a1f7859a7816ff6·
Executives●Purchase0SEBI
€18,757750 shares@ €25.0094
Equity Shares
SEBI:82570202cc83650f91154b56cb16ccfe75de1d11·
Ideal exit: 20 Jun 2026 (T+270)
25 of 875 declarations